Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy

Abstract Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.

Saved in:
Bibliographic Details
Main Authors: Elisa Meucci, Anna Radice, Filippo Fassio, Maria Loredana Chiara Iorno, Donatella Macchia
Format: article
Language:EN
Published: Wiley 2021
Subjects:
R
Online Access:https://doaj.org/article/5e76b6d89eee413f87ad7fef882ea071
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items